96 related articles for article (PubMed ID: 9336399)
1. Brain nitric oxide synthase messenger RNA in central mineralocorticoid hypertension.
Takeda Y; Miyamori I; Yoneda T; Furukawa K; Inaba S; Takeda R; Mabuchi H
Hypertension; 1997 Oct; 30(4):953-6. PubMed ID: 9336399
[TBL] [Abstract][Full Text] [Related]
2. Decreased gene expression of neuronal nitric oxide synthase in hypothalamus and brainstem of rats in heart failure.
Patel KP; Zhang K; Zucker IH; Krukoff TL
Brain Res; 1996 Sep; 734(1-2):109-15. PubMed ID: 8896816
[TBL] [Abstract][Full Text] [Related]
3. Gene expression of brain nitric oxide synthase and soluble guanylyl cyclase in hypothalamus and medulla of two-kidney, one clip hypertensive rats.
Krukoff TL; Gehlen F; Ganten D; Wagner J
Hypertension; 1995 Jul; 26(1):171-6. PubMed ID: 7541780
[TBL] [Abstract][Full Text] [Related]
4. Increased gene expression of neuronal nitric oxide synthase in brain of adult spontaneously hypertensive rats.
Plochocka-Zulinska D; Krukoff TL
Brain Res Mol Brain Res; 1997 Sep; 48(2):291-7. PubMed ID: 9332726
[TBL] [Abstract][Full Text] [Related]
5. Reduced functional expression and molecular synthesis of inducible nitric oxide synthase in rostral ventrolateral medulla of spontaneously hypertensive rats.
Chan JY; Wang LL; Wu KL; Chan SH
Circulation; 2001 Oct; 104(14):1676-81. PubMed ID: 11581148
[TBL] [Abstract][Full Text] [Related]
6. An aldosterone-related system in the ventrolateral medulla oblongata of spontaneously hypertensive and Wistar-Kyoto rats.
Kumar NN; Goodchild AK; Li Q; Pilowsky PM
Clin Exp Pharmacol Physiol; 2006; 33(1-2):71-5. PubMed ID: 16445702
[TBL] [Abstract][Full Text] [Related]
7. Effect of central amiloride infusion on mineralocorticoid hypertension.
Gomez-Sanchez EP; Gomez-Sanchez CE
Am J Physiol; 1994 Nov; 267(5 Pt 1):E754-8. PubMed ID: 7977727
[TBL] [Abstract][Full Text] [Related]
8. Unique levels of expression of N-methyl-D-aspartate receptor subunits and neuronal nitric oxide synthase in the rostral ventrolateral medulla of the spontaneously hypertensive rat.
Edwards MA; Loxley RA; Powers-Martin K; Lipski J; McKitrick DJ; Arnolda LF; Phillips JK
Brain Res Mol Brain Res; 2004 Oct; 129(1-2):33-43. PubMed ID: 15469880
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone acts on the kidney, not the brain, to cause mineralocorticoid hypertension in sheep.
León LA; McKinley MJ; McAllen RM; May CN
J Hypertens; 2002 Jun; 20(6):1203-8. PubMed ID: 12023692
[TBL] [Abstract][Full Text] [Related]
10. Differential cardiovascular responses to blockade of nNOS or iNOS in rostral ventrolateral medulla of the rat.
Chan SH; Wang LL; Wang SH; Chan JY
Br J Pharmacol; 2001 Jun; 133(4):606-14. PubMed ID: 11399678
[TBL] [Abstract][Full Text] [Related]
11. Significance of 19-noraldosterone, a new mineralocorticoid, in clinical and experimental hypertension.
Takeda Y; Miyamori I; Takeda R
Steroids; 1995 Jan; 60(1):137-42. PubMed ID: 7792799
[TBL] [Abstract][Full Text] [Related]
12. Role of brain corticosterone and aldosterone in central angiotensin II-induced hypertension.
Huang BS; White RA; Ahmad M; Leenen FH
Hypertension; 2013 Sep; 62(3):564-71. PubMed ID: 23856493
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure (CRF).
Ye S; Nosrati S; Campese VM
J Clin Invest; 1997 Feb; 99(3):540-8. PubMed ID: 9022090
[TBL] [Abstract][Full Text] [Related]
14. Activation of mineralocorticoid receptors in the rostral ventrolateral medulla is involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats.
Nakagaki T; Hirooka Y; Matsukawa R; Nishihara M; Nakano M; Ito K; Hoka S; Sunagawa K
Hypertens Res; 2012 Apr; 35(4):470-6. PubMed ID: 22237482
[TBL] [Abstract][Full Text] [Related]
15. Role of brain aldosterone and mineralocorticoid receptors in aldosterone-salt hypertension in rats.
Wang HW; Huang BS; Chen A; Ahmad M; White RA; Leenen FH
Neuroscience; 2016 Feb; 314():90-105. PubMed ID: 26656220
[TBL] [Abstract][Full Text] [Related]
16. Expression of nitric oxide synthase isoforms in hypothalamo-pituitary-adrenal axis during the development of spontaneous hypertension in rats.
Häuser W; Sassmann A; Qadri F; Jöhren O; Dominiak P
Brain Res Mol Brain Res; 2005 Aug; 138(2):198-204. PubMed ID: 15913838
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of inducible nitric oxide synthase in rostral ventrolateral medulla causes hypertension and sympathoexcitation via an increase in oxidative stress.
Kimura Y; Hirooka Y; Sagara Y; Ito K; Kishi T; Shimokawa H; Takeshita A; Sunagawa K
Circ Res; 2005 Feb; 96(2):252-60. PubMed ID: 15591232
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of basal iNOS at the rostral ventrolateral medulla is innate in SHR.
Chan JY; Wang LL; Chao YM; Chan SH
Hypertension; 2003 Mar; 41(3):563-70. PubMed ID: 12623960
[TBL] [Abstract][Full Text] [Related]
19. High blood pressure enhances brain stem neuronal nitric oxide synthase activity in Dahl salt-sensitive rats.
Tandai-Hiruma M; Kato K; Kemuriyama T; Ohta H; Tashiro A; Hagisawa K; Nishida Y
Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):197-204. PubMed ID: 23278407
[TBL] [Abstract][Full Text] [Related]
20. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure.
van den Berg DT; de Kloet ER; van Dijken HH; de Jong W
Endocrinology; 1990 Jan; 126(1):118-24. PubMed ID: 2293978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
